Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Endocrine 1Breast 1

Conditions

Urologic Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Radiation Injuries 1Patient Satisfaction 1Patient Acceptance of Health Care 1Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × delta 24-sterol reductase × Clear all
NCT04590976 2023-02-08

IP5-MATTER

Imperial College London

Completed
320 enrolled
Genitourinary

Patient Acceptance of Health Care, Radiation Injuries, Urologic Neoplasms, Patient Satisfaction

NCT02178345 2021-12-08

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Completed
123 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT02579980 2019-03-26

Quantitative Imaging Biomarkers for Sarcoma

Columbia University

Phase NA Completed
32 enrolled
Sarcoma

Sarcoma

NCT00582764 2015-07-08

Quantitative Dynamic Contrast Enhanced Breast MRI

Memorial Sloan Kettering Cancer Center

Completed
116 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡